Clinical Trial Update: Acute Dose Response of Korean White Ginseng in Metabolic Syndrome or Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the acute dose response of Korean White Ginseng in individuals with metabolic syndrome or type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Type 2 Diabetes Mellitus

Drugs mentioned

• Korean White Ginseng (Panax ginseng)

Snippet

Sponsor: Unity Health Toronto | Conditions: Type 2 Diabetes, Metabolic Syndrome | Phase 1 | Status: COMPLETED